Covid-19 roundup: Glax­o­SmithK­line man­dates vac­cines as lat­est phar­ma to join the push; South Africa's As­pen wants to li­cense J&J jab

Glax­o­SmithK­line will join the grow­ing list of biotechs that man­date vac­ci­na­tions for its US em­ploy­ees, and a com­pa­ny spokesper­son said it is look­ing in­to UK pol­i­cy as well.

Com­ple­men­tary work­ers and vis­i­tors to its sites will al­so need to be ful­ly vac­ci­nat­ed, the com­pa­ny said. The pol­i­cy will be put in­to place in the next few weeks, and ex­cep­tions will be made for those with dis­abil­i­ties, med­ical con­di­tions or re­li­gious ex­emp­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER